Outcomes of physical therapy, speech pathology, and occupational therapy for people with motor neuron disease: A systematic review

Neurorehabilitation and Neural Repair

Volumn 20, Issue 3, 2006, Pages 424-434

  Morris, Meg E ^a,b   Perry, Alison ^c   Bilney, Belinda ^a,d   Curran, Andrea ^a,e   Dodd, Karen ^c   Wittwer, Joanne E ^c   Dalton, Gregory W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Rehabilitation and Aged Care Program   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d Ballarat Health   (Australia)

^e Department of Human Services ^*

Author keywords

Amyotrophic lateral sclerosis; Motor neuron disease; Occupational therapy; Physical therapy; Rehabilitation; Speech pathology; Systematic review

Indexed keywords

BIBLIOGRAPHIC DATABASE; DAILY LIFE ACTIVITY; DISABILITY; DISEASE CLASSIFICATION; DYSARTHRIA; EVIDENCE BASED MEDICINE; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; LUNG FUNCTION; MOTOR NEURON DISEASE; MUSCLE STRENGTH; OCCUPATIONAL THERAPY; OUTCOMES RESEARCH; PHYSIOTHERAPY; QUALITY OF LIFE; REVIEW; SPEECH THERAPY; SYSTEMATIC REVIEW;

HUMANS; MOTOR NEURON DISEASE; OCCUPATIONAL THERAPY; PHYSICAL THERAPY MODALITIES; SPEECH-LANGUAGE PATHOLOGY; TREATMENT OUTCOME;

EID: 33746597860     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968305285092     Document Type: Review

References (89)

1. Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992;55(12):1106-15.
2. Emery AE. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1991;1(1):19-29.
3. Bradley WG. Overview of motor neuron disease: classification and nomenclature. Clin Neurosci 1995;3(6):323-6.
4. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature. Can J Neurol Sci 1991;18(1):45-58.
5. Francis K, Bach JR, DeLisa JA. Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil 1999;80(8):951-63.
6. Kondo K. Epidemiology of motor neuron disease. In: Leigh PN, Swash M, eds. Motor neuron disease: biology and management. New York: Springer-Verlag; 1995:19-33.
7. Forshew DA, Bromberg MB. A survey of clinicians' practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4(4):258-63.
8. Kasarskis E. Disease-modifying interventions. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;1:76-8.
9. World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva: WHO Press; 2001.
10. Radunovic A, Leigh PN. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlations between genotype and clinical features. J Neurol Neurosurg Psychiatry 1996;61(6):565-72.
11. Al-Chalabi A, Leigh PN. Recent advances in amyotrophic lateral sclerosis. Curr Opin Neurol 2000;13(4):397-405.
12. Rosen DR, Siddique T, Patterson D, and others Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362(6415):59-62.
13. Bergeron C. Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis. J Neurol Sci 1995;129(Suppl):81-4.
14. Cookson MR, Shaw PJ. Oxidative stress and motor neurone disease. Brain Pathol 1999;9(1):165-86.
15. Beal MF. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. Biofactors 1999;9(2-4):261-6.
16. Mazzini L, Testa D, Balzarini C, Mora G. An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis. J Neurol 1994;241(4):223-7.
17. Jossan SS, Ekblom J, Gudjonsson O, Hagbarth KE, Aquilonius SM. Double blind cross over trial with deprenyl in amyotrophic lateral sclerosis. J Neural Transm Suppl 1994;41:237-41.
18. Louwerse ES, Weverling GJ, Bossuyt PM, Meyjes FE, de Jong JM. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995;52(6):559-64.
19. Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol 1997;244(Suppl 2):S3-14.
20. Lin CL, Bristol LA, Jin L, and others Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998;20(3):589-602.
21. Miller RG, Rosenberg JA, Gelinas DF, and others Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Neurology 1999;52:1311-23.
22. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994;330(9):585-91.
23. Riviere M, Meininger V, Zeisser P, Munsat T. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol 1998;55(4):526-8.
24. Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews 2002; Issue 2. Art No: CD001447. DOI: 10.1002/14651858. CD001447.
25. Jackson CE, Rosenfeld J. Motor neuron disease. Phys Med Rehabil Clin North Am 2000;12(2):335-52.
26. Patel S, Maragakis N. Amyotrophic lateral sclerosis: pathogenesis, differential diagnosis, and potential interventions. J Spinal Cord Med 2002;25(4):262-73.
27. Leigh PN, Abraham S, Al-Chalabi A, and others The management of motor neurone disease. J Neurol Neurosurg Psychiatry 2003;74(Suppl 4):32-47.
28. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. Br Med J 2001;323:334-6.
29. Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil 1999;80(9):1013-6.
30. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67(2):206-7.
31. Haas BM, Bergstrom E, Jamous A, Bennie A. The inter rater reliability of the original and of the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury. Spinal Cord 1996;34(9):560-4.
32. Kloos AD, Dal Bello-Haas V, Thome R, and others Interrater and intrarater reliability of the Tinetti Balance Test for individuals with amyotrophic lateral sclerosis. J Neurol Phys Ther 2004;28(1):12-19.
33. Hollis M. Practical exercise therapy. 2nd ed. Oxford, UK: Blackwell Scientific; 1976.
34. Ashworth NL, Satkunam LE, Deforge D. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2004; Issue 1. Art No: CD004156. DOI: 10.1002/14651858 .CD004156.pub2.
35. Drory VE, Goltsman E, Reznik G, and others The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001;191(1):133-7.
36. Pinto AC, Alves M, Nogueira A, and others Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci 1999;169(1-2):69-75.
37. Gross D, Meiner Z. The effect of ventilatory muscle training on respiratory function and capacity in ambulatory and bed-ridden patients with neuromuscular disease. Monaldi Arch Chest Dis 1993;48(4):322-6.
38. Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993;104(5):1553-62.
39. Bach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehahil 1995;76(9):828-32.
40. Chan CW, Sinaki M. Rehabilitation management of the amyotrophic lateral sclerosis patient. In: Belsh JM, Schiffmann PL, eds. Amyotrophic lateral sclerosis: diagnosis and management for the clinician. New York: Futura; 1996:315-31.
41. Carter G. Rehabilitation management in neuromuscular disease. J Neurol Rehabil 1997;11:69-80.
42. Lenman J. A clinical and experimental study of the effects of exercise on motor weakness in neurological disease. J Neurol Neurosurg Psychiatry 1959;22:182-94.
43. Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis. A case report. Phys Ther 1983;63(6):965-8.
44. Dal Bello-Hass V, Kloos A, Mitsumoto H. Physical therapy for a patient through six stages of amyotrophic lateral sclerosis. Phys Ther 1998;78(12):1312-24.
45. Schwab R, England A. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham J, Donladson I, eds. Third symposium on Parkinson's disease. Edinburgh, UK: Churchill Livingstone; 1969:152-7.
46. Handa I, Matsushita N, Ihashi K, and others A clinical trial of therapeutic electrical stimulation for amyotrophic lateral sclerosis. Tohoku J Exp Med 1995;175(2):123-34.
47. Esposito SJ, Mitsumoto H, Shanks M. Use of palatal lift and palatal augmentation prostheses to improve dysarthria in patients with amyotrophic lateral sclerosis. J Prosthet Dent 2000;83(1):90-8.
48. Robbins J. Swallowing in ALS and motor neurone disorders. Neurol Clin 1987;5:213-29.
49. Johnson CR. Aquatic therapy for an ALS patient. Am J Occup Ther 1988;42(2):115-20.
50. O'Gorman B. Multiclisciplinary care. In: Oliver D, Domenico Borasio G, Walsh D, eds. Palliative care in amyotrophic lateral sclerosis. New York: Oxford University Press; 2001:105-25.
51. DeLisa JA, Mikulic MA, Miller RM, Melnick RR. Amyotrophic lateral sclerosis: comprehensive management. Am Fam Physician 1979;19(3):137-42.
52. Newrick PG, Langton-Hewer R. Pain in motor neuron disease. J Neurol Neurosurg Psychiatry 1985;48(8):838-40.
53. Zawondniak J. Exercise, ambulation and pulmonary physical therapy for the amyotrophic lateral sclerosis patient. In: Caroscio JT, ed. Amyotrophic lateral sclerosis; a guide to patient care. New York: Thieme Medical; 1986:219-44.
54. Vignos P. Management of musculoskeletal complications inneuromuscular disease: limb contractures and the role of stretching and braces and surgery. Phys Med Rehabil: State Art Rev 1988;2:509-36.
55. Silverstein MD, Stocking CB, Antel JP, Beckwith J, Roos RP, Siegler M. Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc 1991;66(9):906-13.
56. Mitsumoto H, Norris F. Amyotrophic lateral sclerosis: a comprehensive guide to management. New York: Demos; 1994.
57. Norris F. Care of the amyotrophic lateral sclerosis patient. In: Mitsumoto H, Norris F, eds. Amyotrophic lateral sclerosis: a comprehensive guide to management. New York: Demos; 1994:29-42.
58. Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve 1995;18(7):741-52.
59. Sifit R. Symptomatic treatment of ALS. Neurology 1997;48:S15-22.
60. Miller RG, Rosenberg JA, Gelinas DF, and others The AAN practice parameter for amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999;52(7):1311-23.
61. Turner M. The treatment of motor neurone disease. Practitioner 2001;245(1623):530-2, 36-8.
62. Dworkin JP, Hartman DE. Progressive speech deterioration and dysphagia in amyotrophic lateral sclerosis: case report. Arch Phys Med Rehabil 1979;60(9):423-5.
63. Campbell MJ, Enderby P. Management of motor neurone disease. J Neurol Sci 1984;64(1):65-71.
64. Carter GT, Miller RG. Comprehensive management of amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 1998;9(1):271-84.
65. Sinaki M, Mulder DW. Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clin Proc 1978;53(3):173-8.
66. Perry A. What can speech therapy offer the motor neurone disease patient? In: Clifford Rose F, ed. Research progress in motor neurone disease. Bath, UK: Pitman; 1984:448-56.
67. Corr B, Frost E, Traynor BJ, Hardiman O. Service provision for patients with ALS/MND: a cost-effective multidis- ciplinary approach. J Neurol Sci 1998;160(1):141-5.
68. Ball LJ, Beukelman DR, Pattee GL. Acceptance of augmentative and alternative communication technology by persons with amyotrophic lateral sclerosis. AAC: Augment Altern Commun 2004;20(2):113-22.
69. Mady S. Surgery for dysphagia in motor neurone disease. In: Clifford Rose F, ed. Research progress in motor neurone disease. Bath, UK: Pitman; 1984:443-6.
70. Braile LE. Support for the drooping head. Am J Occup Ther 1981;35(10):661-2.
71. Driessen MJ, Dekker J, Lankhorst G, van der Zee J. Occupational therapy for patients with chronic diseases: CVA, rheumatoid arthritis and progressive diseases of the central nervous system. Disabil Rehabil 1997;19(5):198-204.
72. Janiszewski DW, Caroscio JT, Wisham LH. Amyotrophic lateral sclerosis: a comprehensive rehabilitation approach. Arch Phys Med Rehabil 1983;64(7):304-7.
73. Lamb M, Harris M. Juggling home care needs in a rural fishing community in Newfoundland. Occup Ther Now 2003;5(5):1.
74. Iezzoni LI. A 44-year-old woman with difficulty walking [see Comment]. JAMA 2000;284(20):2632-9.
75. Turner MR, Parton MJ, Leigh PN. Clinical trials in ALS: an overview. Semin Neurol 2001;21(2):167-75.
76. Dal Bello-Haas V. A framework for rehabilitation of neurodegenerative diseases: planning care and maximizing quality of life. Neurol Rep 2002;26(3):115-29.
77. Sanjak M, Paulson D, Sufit R, and others Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology 1987;37(7): 1217-20.
78. Peruzzi AC, Potts AF. Physical therapy intervention for persons with amyotrophic lateral sclerosis. Physiother Can 1996;48(2):119-26.
79. Sinaki M. Physical therapy and rehabilitation techniques for patients with amyotrophic lateral sclerosis. Adv Exp Med Biol 1987; 209:239-52.
80. Fowler WM Jr, Taylor M. Rehabilitation management of muscular dystrophy and related disorders: the role of exercise. Arch Phys Med Rehabil 1982;63(7):319-21.
81. Moxley RT. The role of exercise. In: Mulder DW, ed. The diagnosis and treatment of amyotrophic lateral sclerosis. Boston: Houghton-Mifflin; 1980:195-214.
82. Brinkmann JR, Ringel SP. Effectiveness of exercise in progressive neuromuscular disease. J Neurol Rehabil 1991;5:195-9.
83. Puszko S. Geriatric massage. Lou Gehrig's disease and massage. Massage Bodywork 2003;18(1):144-6.
84. Ball LJ, Beukelman DR, Pattee GL. Communication effectiveness of individuals with amyotrophic lateral sclerosis. J Commun Dis 2004;37(3):197-215.
85. Chetney R, Waro K. A new home health approach to swallowing disorders. Home Healthcare Nurse 2004;22(10):703-9.
86. O'Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. BMJ 1992;304(6825):471-3.
87. Hartman EE, Delbanco T. A 44-year-old woman with difficulty walking, 2 years later. JAMA 2002;288:2598.
88. Pentland B, Rainey ME, Macneill R. Wheelchair provision for patients with motor neurone disease. Health Bull (Edinb) 1985;43(2):72-5.
89. Trail M, Nelson N, Van JN, Appel SH, Lai EC. Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences. Arch Phys Med Rehabil 2001;82(1):98-102.